Dietary Supplements
Dietary Supplements - Related Videos
09:38
Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
0 Views •
Cited by 59 •
2013
Caenorhabditis elegans is a useful model to explore the functions of polyunsaturated fatty acids in development and physiology. This protocol describes an efficient method of supplementing the C. elegans diet with polyunsaturated fatty acids.
07:33
Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
0 Views •
Cited by 20 •
2015
We describe a simple approach for diagnosis of halitosis in dogs as well as a dietary approach for its management. This protocol may be extended to the management of halitosis in humans in the near future.
09:04
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
0 Views •
Cited by 92 •
2014
DNBS/TNBS induced colitis offers an alternative and inexpensive method to study the pathobiology of inflammatory bowel disease. The protocol discussed in this paper outlines the successful application of DNBS to induce colitis in mice and rats and allows one to thoroughly study host-mediated intestinal responses.
06:13
Solid Plate-based Dietary Restriction in Caenorhabditis elegans
0 Views •
Cited by 19 •
2011
Here we present a protocol for performing solid plate-based dietary restriction in C. elegans with killed bacteria.
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
0 Views •
Cited by 18 •
2017
Current treatments of inflammatory bowel diseases (IBD) aim at alleviating disease symptoms but may cause severe side effects. Thus, alternative strategies are being investigated in animal colitis models. Here, we explain how the beneficial effects of diet supplements on clinical IBD signs are analyzed in such a colitis model.
FAQs
Their ingredients may affect neurotransmitter production, receptor signaling, or energy metabolism, creating pathways through which supplementation could relate to cognition, mood, stress, or behavior. These pathways do not establish a guaranteed psychological benefit. Controlled research is needed to determine whether observed changes reflect a biological response, differences in usual intake, or participants’ expectations about taking the product.
A participant’s starting nutritional status can shape the outcome of supplementation. Someone with different baseline nutrition may respond differently from someone whose usual intake already supplies relevant nutrients or compounds. Researchers therefore account for baseline nutrition when interpreting results, because an apparent effect may depend on what participants were already consuming before exposure began.
Expectations can influence reported or observed psychological outcomes independently of the supplement’s physiological action. Participants who believe a product will improve mood, reduce stress, or sharpen cognition may respond differently from those with no such expectation. Comparing supplement exposure with a placebo helps researchers separate these expectation-related effects from changes associated with the tested ingredients.
Dosage helps define the exposure being evaluated, while medication interactions can complicate both interpretation and safety. A result observed at one dosage may not apply to another, and concurrent medication use may affect the supplement’s apparent psychological or biological effects. Accounting for these factors allows researchers to distinguish the tested exposure from other influences on outcomes.
Researchers define the supplement exposure, select psychological or behavioral outcomes, and compare participants receiving the supplement with a placebo or their usual intake. They also account for dosage, baseline nutrition, expectations, and medication interactions. The resulting comparisons help determine whether changes in cognition, mood, stress, or behavior are associated with the supplement rather than unrelated conditions.
A placebo group provides a comparison for expectation-related responses, whereas a usual-intake comparison shows outcomes against participants’ existing dietary patterns. Using these reference points helps researchers evaluate whether exposure is associated with changes beyond ordinary intake or belief about treatment. The choice of comparison directly affects how confidently investigators can interpret psychological and physiological findings.
Studies may examine cognition, mood, stress, and behavior, while also considering biological pathways related to neurotransmitter production, receptor signaling, or energy metabolism. These outcomes connect physiological processes with psychological effects. Measuring several types of outcome can help researchers assess whether a supplement is associated with a behavioral change, a biological change, or both.
Controlled evidence can help distinguish potential benefits from risks and separate physiological effects from placebo responses. In psychology, that distinction matters because expectations and biological pathways may both influence cognition, mood, stress, and behavior. Findings can therefore support more evidence-based guidance by showing which observed outcomes are linked to the supplement exposure and which may reflect other factors.